The Patent Finder

Zevra Denmark A/S

Also on record
Records under this name other than the patents Zevra Denmark A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.

Back to Zevra Denmark A/S

PatentTitleStatus Expires Confidence
US 12,576,076Use of HSP70 as a Regulator of Enzymatic Activity
In force
 · Medium confidence
In forceMedium confidence
17/059,516HSP70 Protein Levels in PBMC Samples as Biomarker for Disease
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
17/560,549Use of Arimoclomol in the Treatment of Niemann Pick Disease
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
17/574,239Arimoclomol for Treating Glucocerebrosidase Associated Disorders
Abandoned
Abandoned Dec 12, 2025
AbandonedAbandoned Dec 12, 2025
17/855,002Methods for Increasing Intracellular Activity of HSP70
Abandoned
Abandoned Dec 4, 2025
AbandonedAbandoned Dec 4, 2025
18/011,349Arimoclomol for Treating Gaucher Disease
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/037,461Processes for Preparing Arimoclomol Citrate and Intermediates Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/204,025Processes for Preparing Arimoclomol Citrate and Intermediates Thereof
Abandoned
Abandoned Sep 14, 2026
AbandonedAbandoned Sep 14, 2026
18/267,591Arimoclomol for the Treatment of Niemann Pick Disease, Type C, in Patients with Er Type Missense Mutations
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/695,862Dioxazines and Their Use in Treatment of Gba-Related Diseases
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
10 of 15 records shown.
Pro members see all 15.
Pro members: see all 15 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited